321 related articles for article (PubMed ID: 30153063)
1. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.
Kupreeva M; Diane A; Lehner R; Watts R; Ghosh M; Proctor S; Vine D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E16-E33. PubMed ID: 30153063
[TBL] [Abstract][Full Text] [Related]
2. Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.
Vine DF; Wang Y; Jetha MM; Ball GD; Proctor SD
J Clin Endocrinol Metab; 2017 Mar; 102(3):970-982. PubMed ID: 27997268
[TBL] [Abstract][Full Text] [Related]
3. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
[TBL] [Abstract][Full Text] [Related]
4. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
5. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
Xing C; Lv B; Zhao H; Wang D; Li X; He B
J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
[TBL] [Abstract][Full Text] [Related]
6. Androgens exacerbate hepatic triglyceride accumulation in rats with polycystic ovary syndrome by downregulating MTTP expression.
Wang D; Zhao H; Xing C; Lv B; Wang X; He B
Endocrine; 2024 May; 84(2):735-744. PubMed ID: 37950821
[TBL] [Abstract][Full Text] [Related]
7. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
[TBL] [Abstract][Full Text] [Related]
9. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
10. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α.
Zhao H; Wang D; Xing C; Lv B; Wang X; He B
J Steroid Biochem Mol Biol; 2023 May; 229():106265. PubMed ID: 36737028
[TBL] [Abstract][Full Text] [Related]
12. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
[TBL] [Abstract][Full Text] [Related]
13. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
[TBL] [Abstract][Full Text] [Related]
14. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
15. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
16. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.
Cardoso RC; Burns A; Moeller J; Skinner DC; Padmanabhan V
Endocrinology; 2016 Dec; 157(12):4641-4653. PubMed ID: 27792406
[TBL] [Abstract][Full Text] [Related]
17. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
18. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
19. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
